454 related articles for article (PubMed ID: 27565169)
21. KDIGO (Kidney Disease: Improving Global Outcomes) criteria could be a useful outcome predictor of cisplatin-induced acute kidney injury.
Mizuno T; Sato W; Ishikawa K; Shinjo H; Miyagawa Y; Noda Y; Imai E; Yamada K
Oncology; 2012; 82(6):354-9. PubMed ID: 22722365
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of renal function using cystatin C-based estimated glomerular filtration rate in patients with urothelial carcinoma treated with gemcitabine and cisplatin chemotherapy.
Nishimura F; Ushijima T; Hamada S; Kadowaki D; Miyamura S; Oniki K; Saruwatari J
J Clin Pharm Ther; 2021 Dec; 46(6):1622-1628. PubMed ID: 34339546
[TBL] [Abstract][Full Text] [Related]
23. Serum creatinine and cystatin C provide conflicting evidence of acute kidney injury following acute ingestion of potassium permanganate and oxalic acid.
Wijerathna TM; Gawarammana IB; Dissanayaka DM; Palanagasinghe C; Shihana F; Dassanayaka G; Shahmy S; Endre ZH; Mohamed F; Buckley NA
Clin Toxicol (Phila); 2017 Nov; 55(9):970-976. PubMed ID: 28535124
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: which dose is more suitable?
Ilhan Y; Onder AH; Ozbay MF; Karakaya G; Sezgin Goksu S; Ozturk B; Coskun HS
Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3403-3413. PubMed ID: 38766796
[TBL] [Abstract][Full Text] [Related]
25. Effects of a DPP4 inhibitor on cisplatin-induced acute kidney injury: study protocol for a randomized controlled trial.
Baek SH; Kim SH; Kim JW; Kim YJ; Lee KW; Na KY
Trials; 2015 May; 16():239. PubMed ID: 26021829
[TBL] [Abstract][Full Text] [Related]
26. Acute Kidney Injury after Partial Nephrectomy: Role of Parenchymal Mass Reduction and Ischemia and Impact on Subsequent Functional Recovery.
Zhang Z; Zhao J; Dong W; Remer E; Li J; Demirjian S; Zabell J; Campbell SC
Eur Urol; 2016 Apr; 69(4):745-752. PubMed ID: 26525838
[TBL] [Abstract][Full Text] [Related]
27. Reappraisal of short-term low-volume hydration in cisplatin-based chemotherapy: results of a prospective feasibility study in advanced lung cancer in the Okayama Lung Cancer Study Group Trial 1002.
Hotta K; Takigawa N; Hisamoto-Sato A; Ichihara E; Kudo K; Uchida K; Yanase-Nakamura K; Tanaka H; Kato Y; Tabata M; Tanimoto M; Kiura K
Jpn J Clin Oncol; 2013 Nov; 43(11):1115-23. PubMed ID: 24082005
[TBL] [Abstract][Full Text] [Related]
28. Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG).
Bamias A; Peroukidis S; Stamatopoulou S; Tzannis K; Koutsoukos K; Andreadis C; Bozionelou V; Pistalmatzian N; Papatsoris A; Stravodimos K; Varthalitis I; Karamouzis M; Milaki G; Agorastos A; Kentepozidis N; Androulakis N; Bompolaki I; Kalofonos H; Mavroudis D; Dimopoulos MA
Clin Genitourin Cancer; 2016 Apr; 14(2):e153-9. PubMed ID: 26437909
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Equations To Estimate Glomerular Filtration Rate and Their Impact on Frequency of Cisplatin-associated Acute Kidney Injury.
Motwani SS; Choueiri TK; Partridge AH; Hu J; Kaymakcalan MD; Waikar SS; Curhan GC
Kidney360; 2021 Feb; 2(2):205-214. PubMed ID: 35373014
[TBL] [Abstract][Full Text] [Related]
30. Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
Pouessel D; Chevret S; Rolland F; Gravis G; Geoffrois L; Roubaud G; Terrisse S; Boyle H; Chevreau C; Dauba J; Moriceau G; Alexandre I; Deplanque G; Chapelle A; Vauleon E; Colau A; Audenet F; Grellety T; Culine S
Eur J Cancer; 2016 Feb; 54():69-74. PubMed ID: 26724422
[TBL] [Abstract][Full Text] [Related]
31. Administration of contrast media just before cisplatin-based chemotherapy increases cisplatin-induced nephrotoxicity.
Sendur MA; Aksoy S; Yaman S; Arik Z; Tugba Kos F; Akinci MB; Civelek B; Yildirim Ozdemir N; Uncu D; Zengin N
J BUON; 2013; 18(1):274-80. PubMed ID: 23613416
[TBL] [Abstract][Full Text] [Related]
32. The comparison of the commonly used surrogates for baseline renal function in acute kidney injury diagnosis and staging.
Thongprayoon C; Cheungpasitporn W; Harrison AM; Kittanamongkolchai W; Ungprasert P; Srivali N; Akhoundi A; Kashani KB
BMC Nephrol; 2016 Jan; 17():6. PubMed ID: 26748909
[TBL] [Abstract][Full Text] [Related]
33. Dipstick albuminuria and acute kidney injury recovery in critically ill septic patients.
Neyra JA; Li X; Yessayan L; Adams-Huet B; Yee J; Toto RD;
Nephrology (Carlton); 2016 Jun; 21(6):512-8. PubMed ID: 26421662
[TBL] [Abstract][Full Text] [Related]
34. Incidence of acute kidney injury among patients with chronic kidney disease: a single-center retrospective database analysis.
Hatakeyama Y; Horino T; Kataoka H; Matsumoto T; Ode K; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Terada Y; Okuhara Y
Clin Exp Nephrol; 2017 Feb; 21(1):43-48. PubMed ID: 26879775
[TBL] [Abstract][Full Text] [Related]
35. Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Klöckl MC; Kasparek AK; Riedl JM; Moik F; Mollnar S; Stotz M; Szkandera J; Terbuch A; Gerger A; Niedrist T; Pichler M; Bauernhofer T; Schilcher G; Zitta S; Rosenkranz AR; Friedl C; Stöger H; Posch F
Sci Rep; 2020 Jul; 10(1):11219. PubMed ID: 32641710
[TBL] [Abstract][Full Text] [Related]
36. Improved long-term survival and renal recovery after acute kidney injury in hospitalized patients: A 20 year experience.
Long TE; Sigurdsson MI; Sigurdsson GH; Indridason OS
Nephrology (Carlton); 2016 Dec; 21(12):1027-1033. PubMed ID: 26660951
[TBL] [Abstract][Full Text] [Related]
37. Long-Term Renal Outcomes after Cisplatin Treatment.
Latcha S; Jaimes EA; Patil S; Glezerman IG; Mehta S; Flombaum CD
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1173-1179. PubMed ID: 27073199
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and outcomes of acute kidney injury using surrogate and imputation methods for missing preadmission creatinine values.
Bernier-Jean A; Beaubien-Souligny W; Goupil R; Madore F; Paquette F; Troyanov S; Bouchard J
BMC Nephrol; 2017 Apr; 18(1):141. PubMed ID: 28454562
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the RIFLE criteria for the diagnosis of Acute Kidney Injury; a retrospective study in South-Western Ghana.
Ephraim RKD; Darkwah KO; Sakyi SA; Ephraim M; Antoh EO; Adoba P
BMC Nephrol; 2016 Jul; 17(1):99. PubMed ID: 27460991
[TBL] [Abstract][Full Text] [Related]
40. [Impact of different methods of estimating renal function on determining eligibility for cisplatin (CDDP)-based chemotherapy in patients with invasive urothelial carcinoma].
Goto T; Yoshimura K; Matsui Y; Shimizu Y; Inoue T; Okubo K; Kamba T; Nishiyama H; Ogawa O
Hinyokika Kiyo; 2011 Dec; 57(12):671-6. PubMed ID: 22240299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
